• PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer https://www.nejm.org/doi/full/10.1056/NEJMoa2201445 2 comments 20/10/2024

• For the first time in history , an experimental cancer drug had a 100 % success rate in a very small clinical trial in the U.S. 12 patients took a drug called Dostarlimab for around six months only to find that their cancer has disappeared , according to a study published in The New England Journal https://www.nejm.org/doi/pdf/10.1056/NEJMoa2201445 3 comments 8/6/2022 science
• Mismatch Repair–Deficient, Locally Advanced Rectal Cancer Result - Remission https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?query=featured_home 3 comments 6/6/2022 science
• Cancer Trial Delivers 'Unheard-of' Result: Complete Remission for Everyone... https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?query=featured_home 5 comments 6/6/2022 science
• New findings were published in the New England Journal of Medicine on Sunday that found all rectal cancer patients given a certain pill were cancer-free. https://www.nejm.org/doi/full/10.1056/NEJMoa2201445 2 comments 6/6/2022 upliftingnews

Linking pages

Related searches:

Search whole site: site:www.nejm.org

Search title: PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

See how to search.